Insights

Novozymes A/S

Nasdaq Copenhagen · LEI 529900T6WNZXD2R3JW38· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Revenue grew 8.5% year over year.
  • Operating margin was 19.6% in 2025.

Last 3 years

Revenue
$4.2B2024$4.6B2025
Operating income
$550.1M2024$896.7M2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
19.6%
Net margin
14.0%
ROE
5.4%
Debt-to-equity
50.6%
Equity ratio
66.4%

USD at €0.91 per $1 (2026-11-20, ExchangeRate-API)

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.